Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA369275
Max Phase: Preclinical
Molecular Formula: C20H23ClN2O2
Molecular Weight: 358.87
Molecule Type: Small molecule
Associated Items:
ID: ALA369275
Max Phase: Preclinical
Molecular Formula: C20H23ClN2O2
Molecular Weight: 358.87
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cn1cccc1CCNC(=O)c1cc(Cl)cc2c1OC1CCCCC21
Standard InChI: InChI=1S/C20H23ClN2O2/c1-23-10-4-5-14(23)8-9-22-20(24)17-12-13(21)11-16-15-6-2-3-7-18(15)25-19(16)17/h4-5,10-12,15,18H,2-3,6-9H2,1H3,(H,22,24)
Standard InChI Key: MXIABTDFHLAMNE-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 358.87 | Molecular Weight (Monoisotopic): 358.1448 | AlogP: 4.07 | #Rotatable Bonds: 4 |
Polar Surface Area: 43.26 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 13.72 | CX Basic pKa: | CX LogP: 3.83 | CX LogD: 3.83 |
Aromatic Rings: 2 | Heavy Atoms: 25 | QED Weighted: 0.89 | Np Likeness Score: -0.62 |
1. Youssefyeh RD, Campbell HF, Airey JE, Klein S, Schnapper M, Powers M, Woodward R, Rodriguez W, Golec S, Studt W.. (1992) Development of high-affinity 5-HT3 receptor antagonists. 2. Two novel tricyclic benzamides., 35 (5): [PMID:1548679] [10.1021/jm00083a015] |
Source(1):